Table 4. Western blotting results for FMRP, GABRθ, mGluR5 and GABRρ2 values expressed as ratios to β-actin and neuronal-specific enolase (NSE) in BA9.
|
ANOVA |
Control |
Schizophrenia |
Bipolar disorder |
|||||
|---|---|---|---|---|---|---|---|---|
| F | P | Protein | P | Protein | P | Protein | P | |
| GABRθ/β-actin | 4.04 | 0.022 | 1.34±0.40 | RG | 1.06±0.32 | 0.017 | 1.07±0.44 | 0.024 |
| GABRρ2/β-actin | 0.38 | NC | 0.23±0.17 | RG | 0.21±0.14 | NC | 0.26±0.23 | NC |
| mGluR5 dimer/β-actin | 1.39 | NC | 0.78±0.38 | RG | 0.57±0.42 | NC | 0.70±0.49 | NC |
| mGluR5 monomer/β-actin | 10.72 | 0.001 | 0.19±0.13 | RG | 0.089±0.058 | 0.001 | 0.071±0.042 | 0.001 |
| FMRP/β-actin | 3.85 | 0.027 | 0.81±0.40 | RG | 0.54±0.40 | 0.018 | 0.56±0.29 | 0.030 |
| β-actin | 0.19 | NC | 7.06±1.68 | RG | 7.31±1.23 | NC | 7.29±1.82 | NC |
| GABRθ/NSE | 4.54 | 0.014 | 1.51±0.40 | RG | 1.23±0.40 | 0.019 | 1.20±0.36 | 0.011 |
| GABRρ2/NSE | 0.54 | NC | 0.26±0.20 | RG | 0.23±0.14 | NC | 0.30±0.27 | NC |
| mGluR5 dimer/NSE | 0.66 | NC | 0.90±0.59 | RG | 0.72±0.67 | NC | 0.74±0.50 | NC |
| mGluR5 monomer/NSE | 8.14 | 0.001 | 0.22±0.17 | RG | 0.11±0.07 | 0.003 | 0.086±0.052 | 0.001 |
| FMRP/NSE | 4.26 | 0.019 | 1.05±0.55 | RG | 0.71±0.50 | 0.029 | 0.64±0.36 | 0.011 |
| NSE | 0.01 | NC | 6.48±1.79 | RG | 6.54±2.27 | NC | 6.44±2.61 | NC |
Abbreviations: ANOVA, analysis of variance; NC, no change; RG, reference group.
Bold values indicate significant (P<0.05) values.